1. The role of the miR‐148/‐152 family in physiology and disease
   Michael Friedrich et al, 2017, European Journal of Immunology CrossRef
2. Transition from physical activity to inactivity increases skeletal muscle miR-148b content and triggers insulin resistance
   Caroline Gastebois et al, 2016, Physiological Reports CrossRef
3. Screening and identification of four serum miRNAs as novel potential biomarkers for cured pulmonary tuberculosis
   Chong Wang et al, 2018, Tuberculosis CrossRef
4. Regulators at Every Step—How microRNAs Drive Tumor Cell Invasiveness and Metastasis
   Tomasz M. Grzywa et al, 2020, Cancers CrossRef
5. MicroRNA-204 suppressed proliferation and motility capacity of human hepatocellular carcinoma via directly targeting zinc finger E-box binding homeobox 2
   Bin Hu et al, 2017, Oncology Letters CrossRef
6. microRNAs: Key players in virus‐associated hepatocellular carcinoma
   Javid Sadri Nahand et al, 2019, Journal of Cellular Physiology CrossRef
7. MiR-148b-3p inhibits renal carcinoma cell growth and pro-angiogenic phenotype of endothelial cell potentially by modulating FGF2
   Hui Zhang et al, 2018, Biomedicine & Pharmacotherapy CrossRef
8. RETRACTED ARTICLE: lncRNA TINCR sponges miR-214-5p to upregulate ROCK1 in hepatocellular carcinoma
   Min Hu et al, 2020, BMC Medical Genetics CrossRef
9. Dose-Response to Different Radiochemotherapy Regimens in Locally Advanced Pancreatic Cancer
   Brígida C. Ferreira et al, 2020, XV Mediterranean Conference on Medical and Biological Engineering and Computing – MEDICON 2019 CrossRef
10. miRNA-148b and its role in various cancers
    Najmeh Dorraki et al, 2021, Epigenomics CrossRef
11. miR-148b-3p inhibits gastric cancer metastasis by inhibiting the Dock6/Rac1/Cdc42 axis
    Xiaowei Li et al, 2018, Journal of Experimental & Clinical Cancer Research CrossRef
12. Apigenin Inhibits the Growth of Hepatocellular Carcinoma Cells by Affecting the Expression of microRNA Transcriptome
    Shou-Mei Wang et al, 2021, Frontiers in Oncology CrossRef
13. Landmarks in pancreatic cancer studies
    Fan Xu et al, 2022, Cancer Cell International CrossRef
14. Role of Non-Coding RNAs in Hepatocellular Carcinoma Progression: From Classic to Novel Clinicopathogenetic Implications
    Mario Romeo et al, 2023, Cancers CrossRef
15. miRNA-411 acts as a potential tumor suppressor miRNA via the downregulation of specificity protein 1 in breast cancer
    Liangfeng Guo et al, 2016, Molecular Medicine Reports CrossRef
16. Hepigenetics: A Review of Epigenetic Modulators and Potential Therapies in Hepatocellular Carcinoma
    Mohamed H. Yousef et al, 2020, BioMed Research International CrossRef
17. Inhibition of invasion by N -trans -feruloyloctopamine via AKT, p38MAPK and EMT related signals in hepatocellular carcinoma cells
    Zhong-Tian Bai et al, 2017, Bioorganic & Medicinal Chemistry Letters CrossRef
18. Comparison of Different Radiotherapy Techniques for Locally Advanced Pancreatic Tumors
    Adriana Gomes et al, 2020, XV Mediterranean Conference on Medical and Biological Engineering and Computing – MEDICON 2019 CrossRef
19. GABARAPL1 is essential in extracellular vesicle cargo loading and metastasis development
    Joel E.J. Beaumont et al, 2024, Radiotherapy and Oncology CrossRef
20. Targeting ROCK signaling in health, malignant and non-malignant diseases
    Roya Shahbazi et al, 2020, Immunology Letters CrossRef